major groove Hoogsteen H-bonding of the T-A base pair
orientation. Since TFOs incorporating interspersed R-anomer
nucleoside analogues have shown augmented binding stability,6,7
its preparation is also of interest.
Aryl nucleobases have been the most frequent C-nucleoside
of interest in the literature. Effective strategies for production
of aryl C-nucleosides include treatement of Hoffer’s R-chloro-
sugar (3,5-di-O-toluoyl-1-chloro-2-deoxy-R-D-ribofuranose) with
a diaryl cadmium8,9 and Heck coupling of aryl triflates or iodides
to ribofuranoid glycals.10-12 One of the more adaptable
procedures involves treatment of 3,5-di-O-silyl-protected 2-deox-
yribonolactone with an aryllithium and subsequent reduction
of the resulting hemiacetal with Et3SiH.13
FIGURE 4. C1-Vinyl-2-deoxyribofuranose produced by the 5-exo-tet
cyclization mechanism.
SCHEME 1
Regarding C-ethenyl deoxyribose derivatives, a few synthetic
strategies have been reported. The strategy of Takase et al.14
commences with addition of alkynyllithium reagents to 3,5-di-
O-benzyl-2-deoxyribofuranose affording diastereomeric mix-
tures of the corresponding ring-opened alkynyldiols. An in-
tramolecular Nicholas reaction follows giving C-alkynyl-3,5-
di-O-benzyl-2-deoxyribofuranosides with some ꢀ-selectivity.
These may be further modified to C-ethenyl derivatives. In
another example, a one-pot transformation of unprotected
monosaccharides to give styrenyl C-glycosides by Horner-
Wadsworth-Emmons ring closure and tandem halogenation/
Ramberg-Ba¨cklund sequence proceeds in reasonable yield of
the C-ethenyl deoxyribose with equal R and ꢀ anomeric
preference.15 Moreover, the availability of the nucleobase as a
sulfonylphosphonate is a requirement. Also available is a six-
step intramolecular cyclization strategy allowing C-derivatization
via Wittig addition at the C-1 of a protected 5-iodo glucofura-
nose followed by its recyclization to a C-ethenyl 2-deoxy-ꢀ-
ribofuranoside.16 Ring reclosure appears quite steric and requires
relatively high temperatures for cyclization; however, yields are
high for the E-methacrylate example.
An olefin metathesis mediated strategy holds the innate
advantages of its functional group tolerance, thermodynamic
preference for the E-configuration, and mild reaction conditions.
For this reason a strategy employing a metathesis of a C-vinyl
ribofuranose and a vinyl heterocycle was pursued.
A more direct synthesis of the C-vinyl ribose component with
respect to available strategies was sought. Even if the C1-vinyl
hemiacetal could be obtained in reasonable yield by addition
of a vinyl carbanion strategy to a 3,5-di-O-silyl-protected
2-deoxyribonolactone, specific reduction to the C1-vinyl ribo-
furanose would be difficult in the presence of an olefin.
Moreover, employment of the HWE-tandem halogenation/
Ramberg-Backlund or alkynyllithium addition-intramolecular
Nicholas rearrangement strategy could be unnecessarily labori-
ous. However, from a recent work concerning the syntheses of
7-membered carbonates,17 by 5-exo-tet elimination, the 3,5-bis-
O-TBDPS protected C-vinyl 2-deoxy-ꢀ-D-ribofuranose, 3a, was
generated stereospecifically as a side product of triphosgene
addition to the (5S) diol, 2a.
The formation of the C1-vinyl 2-deoxyribofuranose byprod-
uct, 3a, is most likely due to initial acylation at the less hindered
alcohol creating the intermediate (Figure 4) that may follow
two possible cyclization pathways. For the circumstances of their
research the desired 7-membered cyclic carbonate (Figure 4) is
achieved by a 7-exo-trig cyclization. However, the byproduct,
3a, is provided by a 5-exo-tet ring closure with inversion of
configuration at the reacting center by means of an SN2-type
pathway.17
Taking advantage of this observation, the 5-exo-tet ring
closure was effected more directly by addition of MsCl to the
(5S) diol 2a at -20 °C in dichloromethane/pyridine (Scheme
1). This yielded 67% C1-vinyl 2-deoxy-D-ribofuranose with near
complete stereoinversion to give the ꢀ-anomer as no R-anomer
could be isolated or seen by NMR. This would imply an SN2-
type mechanism. The NMR data for the isolated product fully
correspond with that reported by Anderson et al.17 for the
ꢀ-anomer, 3a. Analogously, similar treatment of the (5R) 2b
diol diastereomer stereospecifically yields the R-anomer, 3b.
The starting (5S) 2a, and (5R) 2b diols are obtained from 1,
the 3,5-bis-O-TBDPS protected 2-deoxy-D-ribofuranose18 (Scheme
1), by treatment with excess vinyl magnesium bromide and
separated chromatographically.17 Deprotection of the silyl
moieties was effected with tetra-n-butylammonium fluoride
yielding the C1-vinyl 2-deoxyribofuranose, 4a. A mixture of
the bis-O-TBDMS protected diol analogues was also prepared
by the same method; however, efficient chromatographic
separation was not as satisfactory.
(6) Noonberg, S. B.; Praseuth, D.; Helen, C. Nucleic Acids Res. 1995, 23,
4042–4049, et al.
(7) Debart, F.; Rayner, B.; Degols, G.; Imbach, J.-L. Nucleic Acids Res. 1992,
20, 1193–1200.
(8) Chaudhuri, N. C.; Kool, E. T. Tetrahedron Lett. 1995, 36, 1795–1798.
(9) Pirrung, M. C.; Zhao, X.-D.; Harris, S. V. J. Org. Chem. 2001, 66, 2067–
71.
(10) Hacksell, U.; Daves, G. D. J. Org. Chem. 1983, 48, 2870.
(11) Czernecki, S.; Dechavanne, V. Can. J. Chem. 1983, 61, 533.
(12) Coleman, R. S.; Mortensen, M. A. Tetrahedron Lett. 2003, 44, 1215–
1219.
(13) Wichai, U.; Woski, S. Org. Lett. 1999, 1, 1173–1176.
(14) Takase, M.; Morikawa, T.; Abe, H.; Inouye, M. Org. Lett. 2003, 5,
625–628.
(15) Jeanmart, S.; Taylor, R. J. K. Tetrahedron Lett. 2005, 46, 9043–9048.
(16) Egron, D.; Durand, T.; Roland, A.; Vidal, J.-P.; Rossi, J.-C. Synlett 1999,
4, 435–437.
(17) Anderson, E. A.; Davidson, J. E. P.; Harrison, J. R.; et al. Tetrahedron
2002, 58, 1943–71.
(18) Walker, J. A.; Chen, J.-J.; Wise, D. S.; Townsend, L. B. J. Org. Chem.
1996, 61, 2219–2221.
926 J. Org. Chem. Vol. 74, No. 2, 2009